TTM enters this deal from a strong Aerospace & Defense and advanced-electronics cycle: its latest quarter showed 14% A&D revenue growth, a $1.7 billion A&D program backlog, and Q3 sales guidance of $1.10–$1.14 billion.
The strategic thesis is now real, not just announced. TTM completed the previously disclosed purchase of Epiq, adding software-defined radios, high-performance RF products, and radiation-tolerant space-compute capabilities aimed at signals intelligence and electronic warfare. The deal advances TTM’s effort to move “up the chain” from component manufacturing toward more integrated, mission-critical defense systems. 〔0〕
The economics are mixed rather than immediately accretive to shareholders. Epiq is described as profitable and is expected to lift adjusted EBITDA immediately, but management now explicitly expects moderate non-GAAP EPS dilution in 2027 before EPS accretion in 2028. 〔1〕
| Item | Filing detail |
|---|---|
| Purchase price | Approximately $1.1 billion cash (Acquisition terms) |
| Incremental term loan A | $300 million (Third A&R Credit Agreement) |
| Incremental term loan B | $800 million, seven-year facility (Third A&R Credit Agreement) |
| Existing senior notes used | 6.750% notes due 2034 (Terms of the Transaction & Financing) |
| Expected earnings profile | EBITDA accretive immediately; EPS dilutive in 2027, accretive in 2028 (Closing Press Release) |
Funding increases execution and balance-sheet risk. The purchase was financed with $1.1 billion of new term loans plus proceeds from 6.750% senior notes, and the new facilities are secured by substantially all of TTM’s and its domestic subsidiaries’ assets. That gives TTM the capital to close, but the expected 2027 EPS dilution means the business must grow into the financing burden before the acquisition becomes earnings-accretive.
Most of the surprise was removed before this filing. TTM announced the $1.1 billion Epiq transaction on August 17, 2026, including the broad strategic rationale and the expected 2028 EPS accretion; today’s filing mainly confirms closing and documents the completed financing.
Bottom line: This materially expands TTM’s defense-electronics portfolio and adds a higher-value systems capability, but the near-term payoff is delayed. The event strengthens the strategic story while leaving 2027 earnings and leverage as the key integration tests.
Read the original 8-K on SEC EDGAR ↗